GSK plc (GSK) — Stock Price, Chart & Analysis
GSK plc (GSK) is a Healthcare stock currently trading at $52.96, up 1.51% on the day. It carries a market capitalization of $106.07B and a trailing P/E ratio of 16.50. Over the past 52 weeks, GSK has traded between $37.71 and $61.70. GSK plc pays a dividend yielding 3.5%. View the live GSK chart, technical opinion, analyst ratings, fundamentals and latest news below.
GSK plc (GSK) key data
| Price | $52.96 |
| Change (today) | +1.51% |
| Previous close | $52.17 |
| Market cap | $106.07B |
| P/E ratio (TTM) | 16.50 |
| EPS (TTM) | $3.21 |
| Dividend yield | 3.5% |
| 52-week high | $61.70 |
| 52-week low | $37.71 |
| Beta | 0.29 |
| Avg. volume | 4.02M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about GSK plc (GSK)
How much does one share of GSK plc cost?
As of the latest update, one share of GSK plc (GSK) trades at $52.96 (+1.51% today).
What is GSK plc's market cap?
GSK plc has a market capitalization of approximately $106.07B.
What is GSK plc's P/E ratio?
GSK plc has a trailing price-to-earnings (P/E) ratio of 16.50.
What is GSK plc's earnings per share (EPS)?
GSK plc's trailing twelve-month EPS is $3.21.
Does GSK plc pay a dividend?
Yes — GSK plc pays a dividend with a yield of 3.5% ($1.82 per share annually).
What is GSK plc's 52-week trading range?
Over the past year, GSK has traded between $37.71 and $61.70.
What is the analyst price target for GSK plc?
The mean analyst price target for GSK plc is $58.08. This is informational only and not investment advice.
Latest GSK plc (GSK) news
- GSK plots £400m Cambridge research hub in push for cancer breakthroughNews · Jul 28, 2026
- Global Influenza Vaccine Market Report, 2026 Edition - Profiles GlaxoSmithKline, Pfizer, Sanofi, Moderna, and 9 Other PlayersNews · Aug 7, 2026
- GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook RaisedNews · Aug 5, 2026
- ViiV Healthcare Launches "Do It For Future You" Campaign Inspiring People to Prioritize Their Sexual Health and FutureNews · Aug 4, 2026
- GSK (LSE:GSK) Opens Cambridge Research Hub And Teams Up With Relation TherapeuticsNews · Aug 1, 2026
- IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 OutlookNews · Jul 30, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live GSK dashboard…